Hi, what are you looking for?
On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech, that is a “gem of a company” spun off by Pfizer....
– While federal judge David Carter said Allergan had raised ” serious questions” about the legal implication of Bill Ackman’s Pershing Square and...
In the ongoing hostile pursuit to take over Allergan, major shareholder in the company, Bill Ackman and Valeant just don’t seem ready to quit,...
Wave a magic wand and help any regular investor turn into stock guru. Bippity-boppity–guru! Well, I’m not at all suggesting the new app iBillionaire...
The following guru investors discussed their ideas at the Great Investors Conference (GIBI), courtesy of Valuewalk. Boone Pickens, Founder and CEO of...
"Unlike many CEOs, " said David Pyott, "I'm not interested in what happens to me short-term."
– – The Quebec based drug maker Valeant, led by its CEO Mike Pearson, has been on the acquisition trail again a lot lately,...
– – PlaySight Interactive, an innovative sports technology company and creators of an affordable, tennis analytic system called the ‘SmartCourt’, today announced the completion...
– – The Waterbury Connecticut based chemicals company Platform Specialty Products, said today it has agreed to acquire Chemtura’s AgroSolutions division for US$950 billion...
By Orna Taub / Bill Ackman, CEO of the Pershing Square Capital Management hedge fund, opened this high profile battle with a direct...